Vital Health PodcastVital Health Podcast

VT Discusses MFN and Price Controls

View descriptionShare
 

In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Harry Bowen, Economic Research Partner at Vital Transformation, about Most-Favored-Nation (MFN) drug pricing and the lessons they draw from Europe's experience with price controls. They discuss how pricing rules, revenue uncertainty, and regulatory choices influence market access and the geography of pharmaceutical innovation.

Key Topics:

  • MFN Pricing Incentives: International reference pricing, launch decisions, links between U.S. and European markets.
  • European Approval Trade-offs: Centralized review, national decision-making, consistency and time to market.
  • Investment and Uncertainty: Expected returns, late-stage financing, retrospective clawbacks and revenue planning.
  • Global Innovation Competition: Mobile research investment, changing capabilities, Europe's experience and China's role.
  • Policy and Evidence: Historical comparisons, incentives and unintended effects, distinguishing policy explanations from broader economic change.

Resources Discussed:

Opinions expressed are those of the speakers. Discussion recorded on 9/19/26.

#VitalHealthPodcast #MFN #DrugPricing

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Vital Health Podcast

Duane Schulthess, Managing Director of Vital Tran…
Social links
Follow podcast
Recent clips
Browse 174 clip(s)